迪哲医药-U股价微涨0.29% 创新药领域获机构关注

Group 1 - The latest stock price of Dize Pharmaceutical-U is 82.21 yuan, an increase of 0.24 yuan from the previous trading day, with a trading range of 80.23 to 83.00 yuan and a total transaction amount of 2.31 billion yuan [1] - Dize Pharmaceutical is part of the chemical pharmaceutical sector, focusing on the research and development of innovative drugs, including the globally first high-selective JAK1 inhibitor Golixitinib and LYN/BTK dual-target inhibitors [1] - Research reports indicate that there are significant investment opportunities in the field of hematological malignancies, suggesting attention to Dize Pharmaceutical and other innovative drug companies making progress in overcoming treatment bottlenecks [1] Group 2 - The report highlights a trend in hematological malignancy treatment towards chronic disease management, driven by emerging therapeutic methods such as targeted therapy, immunotherapy, and cell therapy [1] - In terms of capital flow, Dize Pharmaceutical-U experienced a net outflow of 9.2879 million yuan on the day, with a cumulative net outflow of 81.0427 million yuan over the past five days [1]